Page History

...

Expand

title	tx.xpt (trial sets)

Treatment Duration will be controlled? During CT definition/revies will need to decide appropriate Treatment duration values; If not, what are best example values to show?

13B14B15B8C14C15C

Row	STUDYID	ASSAYID	DOMAIN	SETCD	SET	TXPARMCD	TXPARM	TXVAL
1	123	MNT	TX	A1		METACT	Metabolic Activation	+S9
2	123	MNT	TX	A1		TRTDUR	Treatment Duration	Short Term
3	123	MNT	TX	A1		PRDCONC	Concentration of product	0
4	123	MNT	TX	A1		PRDCONCU	Concentration Unit	ug/ml
5	123	MNT	TX	A1		Product	Product Name
6	123	MNT	TX	A1			Smoking Regime
7	123	MNT	TX	A1			Smoke Fraction
	123	MNT	TX	A2		METACT	Metabolic Activation	+S9
	123	MNT	TX	A2		TRTDUR	Treatment Duration	Short Term
	123	MNT	TX	A2		PRDCONC	Concentration of product	1250
	123	MNT	TX	A2		PRDCONCU	Concentration Unit	ug/ml
	123	MNT	TX	A2		Product	Product Name
	123	MNT	TX	A2			Smoking Regime
	123	MNT	TX	A2			Smoke Fraction
	8	123	MNT	TX	BB1		METACT	Metabolic Activation	-S9
	9	123	MNT	TX	BB1		TRTDUR	Treatment Duration	Short Term
10??	123	MNT	TX	BB1		TRTDUR	Treatment Duration	Long Term (or 2 parm codes, # and unit)11
	123	MNT	TX	BB1		PRDCONC	Concentration of product	0
	12	123	MNT	TX	BB1		PRDCONCU	Concentration Unit	ug/ml
	123	MNT	TX	B1		Product	Product Name
	123	MNT	TX	B1			Smoking Regime
	123	MNT	TX	B1			Smoke Fraction
	123	MNT	TX	CC1		METACT	Metabolic Activation	-S9
	9	123	MNT	TX	CC1		TRTDUR	Treatment Duration	Long Term
10??	123	MNT	TX	CC1		TRTDUR	Treatment Duration	Long Term (or 2 parm codes, # and unit)11
	123	MNT	TX	CC1		PRDCONC	Concentration of product	0
	12	123	MNT	TX	CC1		PRDCONCU	Concentration Unit	ug/ml13
	123	MNT	TX	C1		Product	Product Name
	123	MNT	TX	C1			Smoking Regime
	123	MNT	TX	C1			Smoke Fraction

Expand

title	gt.xpt (similar to LB)

BLEO & CPA - positive controls?

Row	STUDYID	ASSAYID	DOMAIN	TXCD	GTSEQ	GTTESTCD	GTTEST	GTCELLEV (cells evaluated)	GTORRES	GTORRESU	GTSTRESC	GTSTRESN	GTSTRESU	GTDTC
1	123	MNT	GT	A2	1	RICC		134	15.7	%	15.7	15.7	%	2022-05-25
2	123	MNT	GT	A2	2	RCC		134	13.0	%	13.0	13.0	%	2022-05-25
3	123	MNT	GT	A2	3	RPD		134	7.9	%	7.9	7.9	%	2022-05-25
4	123	MNT	GT	A2	4	MNCELLS	Micronucleated Cells	3266	20	Cells	20	20	Cells	2022-05-25
5	123	MNT	GT	A2	5	MNCELLS	Micronucleated Cells	2190	17	Cells	17	17	Cells	2022-05-25
6	123	MNT	GT	A2	6	MNCELLS	Micronucleated Cells	2758	13	Cells	13	13	Cells	2022-05-25
7	123	MNT	GT	A2	7	MNCELLS	Micronucleated Cells	2714	21	Cells	21	21	Cells	2022-05-25
8	123	MNT	GT	A2	8	AVGREL	Average Relative MN Frequency		0.66	%	0.66	0.66	%	2022-05-25
9	123	MNT	GT	A1	1	RICC		154	0	%	0	0	%	2022-05-25
10	123	MNT	GT	A1	2	RCC		154	0	%	0	0	%	2022-05-25
11	123	MNT	GT	A1	3	RPD		154	0	%	0	0	%	2022-05-25
12	123	MNT	GT	A1	4	MNCELLS	Micronucleated Cells	3266	15	Cells	15	15	Cells	2022-05-25
13	123	MNT	GT	A1	5	MNCELLS	Micronucleated Cells	2190	13	Cells	13	13	Cells	2022-05-25
14	123	MNT	GT	A1	6	MNCELLS	Micronucleated Cells	2758	17	Cells	17	17	Cells	2022-05-25
15	123	MNT	GT	A1	7	MNCELLS	Micronucleated Cells	2714	12	Cells	12	12	Cells	2022-05-25
16	123	MNT	GT	A1	8	AVGREL	Average Relative MN Frequency		0.57	%	0.57	0.57	%	2022-05-25

...

Page tree

Versions Compared

Old Version 20

New Version 21

Key